Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework-Reference-Cited by-同舟云学术

Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework

Published:2023-05-31 Issue:2 Volume:14 Page:275-305
ISSN:1878-5085
Container-title:EPMA Journal
language:en
Short-container-title:EPMA Journal

Author:

Liu Jinsong^ORCID,Shi Yanjia,Zhang Yuxin

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Health Policy,Drug Discovery

Link

https://link.springer.com/content/pdf/10.1007/s13167-023-00327-3.pdf

Reference103 articles.

1. Hora M, Albiges L, Bedke J, Campi R, Capitanio U, Giles RH, Ljungberg B, Marconi L, Klatte T, Volpe A, et al. European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View. Eur Urol. 2023;83:97–100. https://doi.org/10.1016/j.eururo.2022.11.001.

2. Moch H, Amin MB, Berney DM, Comperat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: RENAL, PENILE AND TESTICULAR TUMours. Eur Urol. 2022;82:458–68. https://doi.org/10.1016/j.eururo.2022.06.016.

3. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. https://doi.org/10.1038/nrdp.2017.9.

4. Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797. https://doi.org/10.1136/bmj.g4797.

5. Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V, Eisen T, Horwich A, Group, E.G.W. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii49-56. https://doi.org/10.1093/annonc/mdu259.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas;Journal of Translational Medicine;2024-08-16

2. Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer;Frontiers in Immunology;2024-08-06

3. Establishing an oxidative stress mitochondria-related prognostic model in hepatocellular carcinoma based on multi-omics characteristics and machine learning computational framework;Discover Oncology;2024-07-16

4. The roles of tertiary lymphoid structures in genitourinary cancers: a comprehensive review of current advances and clinical applications;International Journal of Surgery;2024-07-08

5. Prognostic and therapeutic insights into colorectal carcinoma through immunogenic cell death gene profiling;PeerJ;2024-06-24